Bottom line
SHSCX vs JDOC: the short answer
SHSCX (Blackrock Health Sciences Opportunities Portfolio) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
But SHSCX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 1.9% — a difference of $125 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs +14.1% for SHSCX.
Updated Nov 19, 2026
SHSCX vs JDOC side by side
| SHSCX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | BlackRock | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.9% | 0.65% |
| Annual cost per $10k | $190 | $65 |
| 10-yr cost on $10k (prospectus) | $2,016 | $810 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | +14.1% | +14.9% |
| 5-yr return (annualized) | +4.8% | — |
| 10-yr return (annualized) | +8.9% | — |
| Best quarter | — | +11.3% |
| Worst quarter | — | −11.9% |
| Net assets (fund) | $5.9B | $9.1M |
| Number of holdings | 155 | 61 |
| Portfolio turnover | 49% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of SHSCX's top 25 holdings also appear in JDOC's top 25.
| Holding | SHSCX | JDOC |
|---|---|---|
| Eli Lilly & Company | 12.29% | 7.76% |
| Johnson & Johnson | 8.77% | 4.82% |
| Unitedhealth Group Inc | 6.10% | 5.85% |
| Merck & Company Inc | 4.94% | 4.82% |
| Abbvie Inc | 3.94% | 7.85% |
| Thermo Fisher Scientific Inc | 3.02% | 3.73% |
| Edwards Lifesciences Corp | 2.51% | 1.73% |
| Danaher Corp | 2.00% | 2.16% |
| Abbott Laboratories | 1.97% | 3.11% |
| Intuitive Surgical Inc | 1.95% | 1.93% |
| Biogen Inc | 1.21% | 1.56% |
| Astrazeneca Plc | 1.21% | 3.76% |
| Stryker Corp | 1.15% | 2.23% |
| Regeneron Pharmaceuticals Inc | 0.91% | 1.60% |
Source: SEC Form N-PORT
SHSCX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between SHSCX and JDOC?
Which is cheaper, SHSCX or JDOC?
Should I own both SHSCX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.